Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore
Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion animal health business. BioForLife offers a strong presence in the Italian pet care market. The acquisition is expected to finalize in the second quarter of FY 2026-27.
Viyash Scientific to acquire Milan-based pet care company BioForLife
Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.
Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife
Viyash Scientific rose 1.59% to Rs 259.20 after the company's wholly owned subsidiary, Alivira Animal Health, has inked a binding agreement to acquire a 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy.
Viyash Scientific acquires Italy’s BioForLife in Rs 188-crore European pet-care push
Under the agreement, Viyash will pay EUR 16.975 million (Rs.188 crore) for the acquisition, including deferred consideration, with the transaction expected to close within three months subject to regulatory approvals, the company said in a statement to stock exchanges.